Frequency, cloning efficiency, and GFP expression of stem/progenitor cells, immature (CD71high) and mature (CD71med) erythroid cells, and MKs prospectively isolated from marrow and spleen of −2.7kbGata1GFPGata1+/0 and −2.7kbGata1GFPGata1low/0 mice
. | −2.7kbGata1GFPGata1+/0 . | −2.7kbGata1GFPGata1low/0 . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Frequency . | Cloning efficiency . | GFPneg . | GFPpos . | Frequency . | Cloning efficiency . | GFPneg . | GFPpos . | |||||
% . | AFI . | % . | AFI . | % . | AFI . | % . | AFI . | |||||
Bone marrow | ||||||||||||
Stem/progenitor cells | ||||||||||||
CMP/GMP (cKitpos/CD34pos) | 2.1 | 59.5 ± 5.4 | 90 | 40 | 9 | 110 | 2.1 | 22.8 ± 5.2* | 82 | 90 | 18 | 900 |
Stem/MEP (cKitpos/CD34neg) | 2.7 | 13.6 ± 5.2 | 58 | 35 | 42 | 1200 | 2.8 | 0.1 ± 0.05* | 89 | 65 | 11 | 150 |
Erythroblasts | ||||||||||||
CD71high | 8.8 | na | 8 | bd | 92 | 1632 | 4.3 | na | 0 | bd | 100 | 1695 |
CD71med | 10.2 | na | 2 | bd | 98 | 555 | 1.8 | na | 2 | bd | 98 | 780 |
Megakaryocytes | ||||||||||||
CD61posCD41pos | 3.8 | na | 100 | 20 | 0 | bd | 26.8 | na | 99 | 20 | 1 | bd |
Spleen | ||||||||||||
Stem/progenitor cells | ||||||||||||
CMP/GMP (cKitpos/CD34pos) | 2.2 | 0.2 ±0.1 | 63 | 20 | 36 | 1000 | 2.4 | 72.3 ± 28.4* | 17 | 98 | 40 | 370 |
43 | 10 100 | |||||||||||
Stem/MEP (cKitpos/CD34neg) | 0.6 | 0 | 67 | 40 | 33 | 130 | 1.3 | 18.2 ± 8.9* | 10 | 80 | 47 | 230 |
43 | 12 200 | |||||||||||
Erythroblasts | ||||||||||||
CD71high | 1.2 | na | 4 | bd | 96 | 601 | 2.4 | na | 0 | bd | 100 | 1960 |
CD71med | 1.4 | na | 2 | bd | 98 | 391 | 1.4 | na | 1 | bd | 99 | 860 |
Megakaryocytes | ||||||||||||
CD61posCD41pos | 4.5 | na | 98 | 20 | 1.6 | bd | 26.3 | na | 3 | bd | 97 | 227 |
. | −2.7kbGata1GFPGata1+/0 . | −2.7kbGata1GFPGata1low/0 . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Frequency . | Cloning efficiency . | GFPneg . | GFPpos . | Frequency . | Cloning efficiency . | GFPneg . | GFPpos . | |||||
% . | AFI . | % . | AFI . | % . | AFI . | % . | AFI . | |||||
Bone marrow | ||||||||||||
Stem/progenitor cells | ||||||||||||
CMP/GMP (cKitpos/CD34pos) | 2.1 | 59.5 ± 5.4 | 90 | 40 | 9 | 110 | 2.1 | 22.8 ± 5.2* | 82 | 90 | 18 | 900 |
Stem/MEP (cKitpos/CD34neg) | 2.7 | 13.6 ± 5.2 | 58 | 35 | 42 | 1200 | 2.8 | 0.1 ± 0.05* | 89 | 65 | 11 | 150 |
Erythroblasts | ||||||||||||
CD71high | 8.8 | na | 8 | bd | 92 | 1632 | 4.3 | na | 0 | bd | 100 | 1695 |
CD71med | 10.2 | na | 2 | bd | 98 | 555 | 1.8 | na | 2 | bd | 98 | 780 |
Megakaryocytes | ||||||||||||
CD61posCD41pos | 3.8 | na | 100 | 20 | 0 | bd | 26.8 | na | 99 | 20 | 1 | bd |
Spleen | ||||||||||||
Stem/progenitor cells | ||||||||||||
CMP/GMP (cKitpos/CD34pos) | 2.2 | 0.2 ±0.1 | 63 | 20 | 36 | 1000 | 2.4 | 72.3 ± 28.4* | 17 | 98 | 40 | 370 |
43 | 10 100 | |||||||||||
Stem/MEP (cKitpos/CD34neg) | 0.6 | 0 | 67 | 40 | 33 | 130 | 1.3 | 18.2 ± 8.9* | 10 | 80 | 47 | 230 |
43 | 12 200 | |||||||||||
Erythroblasts | ||||||||||||
CD71high | 1.2 | na | 4 | bd | 96 | 601 | 2.4 | na | 0 | bd | 100 | 1960 |
CD71med | 1.4 | na | 2 | bd | 98 | 391 | 1.4 | na | 1 | bd | 99 | 860 |
Megakaryocytes | ||||||||||||
CD61posCD41pos | 4.5 | na | 98 | 20 | 1.6 | bd | 26.3 | na | 3 | bd | 97 | 227 |
The frequency of stem/progenitor cells is expressed as the percentage of the total mononuclear cells analyzed. The frequency of GFPpos cells is expressed as the percentage of the cells within the corresponding gate. Flow cytometry data correspond to the determinations presented in Figure 4. Similar results were observed in 3 to 4 additional mice per experimental point. Cloning efficiency is reported as the number of day-15 colonies observed in cultures seeded with 100 purified cells and is expressed as mean (± SD) in at least 3 separate determinations per experimental point.
AFI indicates average fluorescence intensity; na, not applicable; and bd, below detection.
Values observed in Gata1low mice statistically different (P < .01) from those observed in mice wild-type at the Gata1 locus.